Palvella Therapeutics (PVLA) Live Share Price, Invest From India

Palvella Therapeutics Stock Performance

as on October 9, 2026 at 2:16 pm IST

Day's Low
Day's High
$124.49
Day's Price Range
$131.93
$131.34
5.22%
Downside
0.45%
Upside
52 Week's Low
52 Week's High
$65.93
52-Week Price Range
$161.38
$131.34
49.80%
Downside
22.87%
Upside

Palvella Therapeutics share price movements today

Previous Close: $130.59
Open: $130.70
Volume: 261.1K
Market Cap: $1.9B
Day's Low - High: $124.49 - $131.93
52 Week Low - High: $65.93 - $161.38

Palvella Therapeutics Historical Returns

1 Month Return: -13.22 %
3 Month Return: -13.04 %
1 Year Return: + 87.39 %
3 Year Return: 0 %
5 Year Return: 0 %

Palvella Therapeutics Stock Fundamentals & Key Indicators

Check Palvella Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-4.83

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-27.04

Industry PE ratio

-6.50

PEG Ratio

-0.93

EBITDA

-50.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-47.84%

Palvella Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Palvella Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Palvella Therapeutics	StrongBuy	$1.9B	NA	-27.04	0.00%	0.00%
Moderna	Neutral	$78.4B	-35.39%	-24.62	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.2B	181.24%	29.19	86.04%	0.00%
Regeneron	Buy	$76.1B	34.46%	17.72	84.86%	0.50%

Stock Returns calculator for Palvella Therapeutics Stock including INR - Dollar returns

The Palvella Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Palvella Therapeutics investment value today

Current value as on today

₹2,04,319

Returns

₹1,04,319

(+104.32%)

Returns from Palvella Therapeutics Stock

₹87,388 (+87.39%)

Dollar Impact

₹16,932 (+16.93%)

Analyst Recommendation on Palvella Therapeutics Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Palvella Therapeutics. Average target price of $234.625

Palvella Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Palvella Therapeutics.

Current Price

$131.34

Analyzed by

8 Analysts

High

$270

Low

$207

Palvella Therapeutics target price $0, a slight upside of 0% compared to current price of $131.34. According to 8 analysts rating.

Indian Investors' Interest in Palvella Therapeutics Stock

Search interest for Palvella Therapeutics Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 9, 2026 to October 9, 2026

Change:-22% versus previous 30 day period

Palvella Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Total Revenue	20	19	1	-	-	-	-	-	-	-
Gross Profit	19	18	1	-	-	-	-	-	-	-
Operating Income	2	3	-5	-1	-2	-7	-9	-10	-14	-21
EBITDA	4	-10	-4	-1	-3	-6	-8	0	-17	-21
Interest Expense	-	-	-	0	1	1	1	1	2	2
Depreciation	0	0	-	-	-	-	-	10	-	-
Income Before Tax	3	-10	-4	-2	-4	-8	-9	-11	-15	-21
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	3	-10	-4	-2	-4	-8	-9	-11	-15	-21
Net Profit Margin	96.38%	96.21%	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Palvella Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Mar 2026
Total Revenue	29	46	29	31	25	-	-	-
Gross Profit	29	-8	29	29	23	-	-	-
Operating Income	-30	-27	-33	-51	-43	-11	-14	-38
EBITDA	-30	-26	-34	-43	-30	18	-13	-35
Interest Expense	-	-	-	-	-	-	4	5
Depreciation	0	1	2	2	2	-	-	-
Income Before Tax	-27	-25	-37	-45	-33	18	-17	-41
Income Tax Expense	0	-1	0	-	-	-	-	-
Net Income	-26	-23	-37	-45	-33	18	-17	-41
Net Profit Margin	100.00%	-18.84%	0.00%	92.46%	89.27%	0.00%	0.00%	0.00%

Palvella Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026	Jun 2026
Net Income	3	-10	-4	-2	-4	-8	-9	-11	-15	-21
Operating Cash Flow	-13	-9	-19	-1	-1	-6	-5	-7	-10	-12
Investing Cash Flow	-1	-1	3	-	-	-	-	-	-55	-7
Financing Cash Flow	19	-	0	-	9	-1	0	0	214	1
Change in Cash	5	-12	-15	1	0	56	-5	-6	148	-18

Palvella Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Mar 2026
Net Income	-26	-25	-37	-45	-27	18	-17	-41
Operating Cash Flow	-1	-52	-45	-7	-14	-13	-10	-25
Investing Cash Flow	-8	9	39	0	-	-	-	-
Financing Cash Flow	48	32	10	59	9	5	87	0
Change in Cash	36	-12	8	47	-5	-31	76	-25

Global Institutional Holdings in Palvella Therapeutics

Check out the Institutions with significant holdings in Palvella Therapeutics.

Funds	Holdings
Vanguard	4.40%
VANGUARD INDEX FUNDS	3.23%
iShares	3.20%
Federated Hermes Equity Funds	2.96%
SPDR	2.86%

See all

Insights on Palvella Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, PVLA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, PVLA stock has moved up by 87.4%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 615.6% return, outperforming this stock by 528.2%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 20.05M → 53.0K (in $), with an average decrease of 64.0% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 7 quarters, -3.95M → -21.87M (in $), with an average decrease of 36.2% per quarter

About Palvella Therapeutics

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.

Organisation	Palvella Therapeutics
Headquarters	353 W. Lancaster Avenue, Wayne, PA, 19087, US
Industry	Biotechnology
CEO	Wesley H. Kaupinen

Key Management of Palvella Therapeutics

Name	Title
Mr. Wesley H. Kaupinen	Founder, President, CEO & Director
Mr. Matthew E. Korenberg	CFO, Corporate Secretary & Treasurer
Dr. Jeffrey Martini Ph.D.	Chief Scientific Officer
Ms. Colleen Kelly J.D.	VP & Head of Legal
Ms. Bohan Wei	Vice President of Corporate Development & New Product Planning
Ms. Kathleen Goin	Chief Operating Officer
Ms. Marcy B. Nanus	Vice President of Investor Relations & Corporate Affairs
Mr. Kent Taylor	Senior Vice President of Sales
Ms. Sarah Foster	Senior Vice President of Human Resources
Ms. Emily Cook	Senior Vice President of Clinical Operations

FAQs

What is Palvella Therapeutics share price today?

Palvella Therapeutics share price today is $131.34 as on October 9, 2026 at 8:46 am IST at the close of the market. Palvella Therapeutics share today touched a day high of $131.93 and a low of $124.49.

What is the 52 week high and 52 week low for Palvella Therapeutics share?

Palvella Therapeutics share touched a 52 week high of $161.38 on June 30, 2026 and a 52 week low of $65.93 on October 10, 2025. Palvella Therapeutics stock price today i.e. October 9, 2026 at 8:46 am IST is closed at $131.34,which is 18.61% down from its 52 week high and 99.21% up from its 52 week low.

What is Palvella Therapeutics's market capitalisation today?

Palvella Therapeutics market capitalisation is $0.00T as on October 9, 2026 at 8:46 am IST.

How to invest in Palvella Therapeutics Stock (PVLA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Palvella Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Palvella Therapeutics Stock (PVLA) from India?

Indian investors can start investing in Palvella Therapeutics (PVLA) shares with as little as ₹96.779998779297 or $1 (as of October 9, 2026 at 10:48 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Palvella Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 9, 2026 at 10:48 am IST). Based on Palvella Therapeutics share’s latest price of $131.34 as on October 9, 2026 at 8:46 am IST, you will get 0.0761 shares of Palvella Therapeutics. Learn more about fractional shares .